Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
diphtheria + tetanus + acellular pertussis + inactivated poliovirus vaccine (adsorbed)
- Development stage
- Approved
- Lead developer
- GSK
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
A **combination vaccine** that provides active immunization against diphtheria, tetanus, pertussis (whooping cough), and poliomyelitis. It contains diphtheria and tetanus toxoids, acellular pertussis antigens (toxoid and other components), and inactivated poliovirus, all adsorbed onto an adjuvant (typically aluminum-based). The mechanism of action is by stimulating humoral and cellular immune responses against these pathogens, providing immunity primarily by the production of protective antibodies. The vaccine is indicated for children from 6 weeks up to 6 years of age, protecting against all four diseases in a single injection. This vaccine excludes additional antigens for hepatitis B or Haemophilus influenzae type b, which may be present in other combination products.
- Brand names
- KinrixQuadracelRepevaxQuattro-backTetrabic
- Other names
- 四種混合mixture of 4
02
Targets
Diphtheria toxin
Beyond the preview
Go deeper on diphtheria + tetanus + acellular pertussis + inactivated poliovirus vaccine (adsorbed).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on diphtheria + tetanus + acellular pertussis + inactivated poliovirus vaccine (adsorbed).